Owens & Minor (OMI) : The consensus on Owens & Minor (OMI) based on 3 analyst recommendation on the company stock is 3.67, which is interpreted as a Sell recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 2 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 1 analyst sees the stock overvalued at current levels and advises a Strong Sell on the stock.
Owens & Minor (OMI) : The highest level Owens & Minor (OMI) is projected to reach is $36 for the short term and the lowest estimate is at $29. The consolidated price target from 4 rating analysts who initiate coverage on the stock is $33 and the possibility the share price can swing is $3.16.
The shares have received a consensus rating of Sell for the current week
Owens & Minor (NYSE:OMI): The stock opened at $34.57 and touched an intraday high of $34.81 on Wednesday. During the day, the stock corrected to an intraday low of $34.45, however, the bulls stepped in and pushed the price higher to close in the green at $34.74 with a gain of 0.64% for the day. The total traded volume for the day was 814,511. The stock had closed at $34.52 in the previous trading session.
Owens & Minor, Inc. is a healthcare logistics company. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company operates in two segments: Domestic and International. Domestic segment includes all functions in the United States relating to its role as a healthcare logistics company providing distribution, packaging and logistics services to healthcare providers and manufacturers. International segment consists of its European third-party logistics and packaging businesses. It is focused on its operations on healthcare logistics services and provides its customers with a service portfolio that covers procurement, inventory management, delivery and sourcing of products for the healthcare market. Its customers include hospitals, integrated healthcare systems, group purchasing organizations, manufacturers of life-science and medical devices and supplies, including pharmaceuticals.